Premature Ejaculation Treatment Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Premature Ejaculation Treatment Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Premature Ejaculation Treatment Market:

https://www.thebusinessresearchcompany.com/report/premature-ejaculation-treatment-global-market-report

According to The Business Research Company’s Premature Ejaculation Treatment Global Market Report 2024, The premature ejaculation treatment market size has grown strongly in recent years. It will grow from $3.53 billion in 2023 to $3.88 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The  growth in the historic period can be attributed to increasing prevalence of premature ejaculation, growing awareness and reduced stigma, physician and patient education, changing societal attitudes toward sexual health, expansion of telemedicine services, pharmaceutical industry initiatives..

The premature ejaculation treatment market size is expected to see strong growth in the next few years. It will grow to $5.62 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to continued focus on sexual health, individualized treatment approaches, global efforts to address sexual dysfunction, online health platforms and apps, increased openness in healthcare discussions.. Major trends in the forecast period include rise in behavioral and psychosexual therapies, development of novel topical therapies, advancements in pharmacological treatments, integration of telemedicine and online platforms, focus on patient education and counseling, research on novel mechanisms of action..

The increasing prevalence of sexual disorders is expected to propel the growth of the premature ejaculation treatment market going forward. Sexual disorder or dysfunction refers to the difficulty faced by both men and women during any phase of regular intimate activity. Premature ejaculation is a sexual disorder where premature ejaculation treatment involving medications or therapeutic approaches addresses and controls this condition. For instance, in November 2021, according to a survey of 2,000 UK adults conducted by Pharmacy Direct GB, a UK-based online pharmacy, around 48% of UK residents reported experiencing erectile dysfunction, representing about 16.5 million individuals. The National Health Service spent over $17,9 million (£13 million) for Erectile Dysfunction treatment prescriptions in 2021. Further, in July 2022, according to a survey of 1,000 men across the UK by Click2Pharmacy, a UK-based provider of local prescription treatment services, around 58.2% experienced erectile dysfunction in the UK and 3 in 4 men between the ages of 25 and 34 experience erectile dysfunction in 2022. Therefore, the increasing prevalence of sexual disorders is driving the growth of the premature ejaculation treatment market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=13518&type=smp

The premature ejaculation treatment market covered in this report is segmented –

1) By Type: Antidepressants (SSRIs), Phosphodiesterase-5 Inhibitors, Topical Anesthetics, Analgesics, Other Treatment

2) By Route of Administration: Oral, Topical

3) By Distribution Channel: Retail, Direct-To-Consumer

4) By Application: Hospital, Retail Pharmacy, Online Pharmacy, Other Applications

Major companies operating in the premature ejaculation treatment market are developing new solutions, such as delay sprays, to drive revenues in the market. Delay sprays, specifically prepared products applied to the penis before sexual activity to assist men last longer during sexual intercourse, work by momentarily dulling penis nerves, lowering penis sensitivity, and postponing ejaculation. For instance, in August 2023, Maude, a US-based sexual wellness company, launched Stay, a delay spray explicitly designed to address premature ejaculation. This product is infused with 10% lidocaine, a fast-evaporating local anesthetic that reduces sensitivity in the male genital region. Furthermore, Stay is compatible with both latex and polyisoprene condoms, as well as various lubricants and devices. It’s vegan-friendly, fragrance-free, and free from sulfates, silicones, and parabens.

The premature ejaculation treatment market report table of contents includes:

 

1. Executive Summary
2. Premature Ejaculation Treatment Market Characteristics
3. Premature Ejaculation Treatment Market Trends And Strategies
4. Premature Ejaculation Treatment Market – Macro Economic Scenario
5. Global Premature Ejaculation Treatment Market Size and Growth

.

.

.

32. Global Premature Ejaculation Treatment Market Competitive Benchmarking
33. Global Premature Ejaculation Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Premature Ejaculation Treatment Market
35. Premature Ejaculation Treatment Market Future Outlook and Potential Analysis
36. Appendix

Top Major Players:

• Pfizer Inc.
• Johnson & Johnson
• AbbVie Inc
• Bayer AG
• Novartis AG

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company  

Twitter: https://twitter.com/tbrc_info  

Facebook: https://www.facebook.com/TheBusinessResearchCompany  

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ  

Blog: https://blog.tbrc.info/  

Healthcare Blog: https://healthcareresearchreports.com/  

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model